MedPath

Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars

Phase 4
Conditions
Pulpitis
Dental Pulp Disease
Tooth Diseases
Interventions
Drug: Formocresol
Drug: Mineral Trioxide Aggregate
Registration Number
NCT02286648
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

The purpose of this study is to evaluate the clinical and radiographic success rate of Miniature pulpotomy with Mineral Trioxide Aggregate (MTA) in primary molars.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • healthy people(without any systemic disease)

  • teeth :

    • no clinical or radiographic evidence of pulp degeneration
    • the possibility of proper restoration of the teeth
Read More
Exclusion Criteria
  • teeth :

    • excessive bleeding from the exposure site
    • internal root resorption
    • interradicular and/or periapical bone destruction
    • swelling or sinus tract
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FormocresolFormocresolpulpotomy with FC
Mineral Trioxide AggregateMineral Trioxide Aggregatepulpotomy with MTA
Primary Outcome Measures
NameTimeMethod
successful outcome of treatment as indicated by clinical signs defined with observation and check listup to 12 months

success or failure of treatment defined with observation and check list

Secondary Outcome Measures
NameTimeMethod
successful outcome of treatment as indicated by radiographic signs defined with observation and check listup to 12 months

success or failure of treatment defined with observation and check list

Trial Locations

Locations (1)

Mashhad University of Medical Siences

🇮🇷

Mashhad, Khorasan Razavi, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath